The possible role of prolactin in autoimmunity.
Buskila
D
D
Division of Medicine Unit, Soroka Medical Center, Ben-Gurion University, Beer-Sheva, Israel.
Sukenik
S
S
Shoenfeld
Y
Y
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001169:Arthritis, Experimental / Q000276:immunology / Q000503:physiopathology; D015535:Arthritis, Psoriatic / Q000188:drug therapy / Q000276:immunology; D001323:Autoantibodies / Q000096:biosynthesis; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D015551:Autoimmunity; D001971:Bromocriptine / Q000494:pharmacology / Q000627:therapeutic use; D016572:Cyclosporine / Q000494:pharmacology / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications; D007111:Immunity, Cellular / Q000187:drug effects; D007121:Immunocompetence; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains / Q000502:physiology; D008817:Mice, Mutant Strains / Q000502:physiology; D011247:Pregnancy; D011248:Pregnancy Complications; D011388:Prolactin / Q000502:physiology*; D051381:Rats; D012216:Rheumatic Diseases / Q000276:immunology / Q000503:physiopathology; D014605:Uveitis / Q000188:drug therapy / Q000276:immunology
D001323:Autoantibodies; D001971:Bromocriptine; D016572:Cyclosporine; D011388:Prolactin